Pepdox
Studies
Peptides
Calculator
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies. | Pepdox
Home
/
Search
/
PMID 33417153
Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies.
Diabetes therapy : research, treatment and education of diabetes and related disorders
2021
PMID: 33417153
View on PubMed
DOI: 10.1007/s13300-020-00976-x
Semaglutide
Authors
Williams, David M; Evans, Marc